Table 1 Summary of demographic and disease characteristics
From: A phase 1 study of tazarotene in adults with advanced cancer
Characteristic | All patients ( n =34) |
|---|---|
Age (years): mean (range) | 58.5 (39–72) |
Male : female; n | 20 : 14 |
Caucasian: n | 34 |
Weight (kg): mean (range) | 72.4 (48–112) |
Site of current cancer: n | |
Colorectal | 6 |
Ovary | 5 |
Mesothelioma | 4 |
Lung | 3 |
Kidney | 3 |
Cervix | 3 |
Breast | 2 |
Skin | 2 |
Other | 6 |
Prior anticancer treatment: na | |
Chemotherapy | 26 |
Radiation therapy | 21 |
Surgery | 16 |
Laser treatment | 1 |
Cryotherapy | 1 |
